Form 4: ANI Pharmaceuticals Executive Chad Gassert Reports Stock Transactions
SEC Filing
Chad Gassert, SVP at ANI Pharmaceuticals, reports disposition of shares for tax purposes following vesting of restricted stock.
Summary
- Chad Gassert, a Senior Vice President at ANI Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On February 29, 2024, 1,635 shares of common stock were disposed of to cover tax obligations related to the vesting of 4,342 shares of restricted stock.
- The shares were disposed of at a price of $67.67 per share.
- Following the transaction, Gassert directly owns 49,679 shares of ANI Pharmaceuticals common stock.
- Gassert also indirectly owns 293,226 shares through Chali Properties LLC.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding process related to stock vesting.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related stock disposal.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of stock transaction (disposal of shares for tax purposes). |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.